VIRX Insider Holders & Insider Ownership - Viracta Therapeutics Inc.

List of insiders holdings for Viracta Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	aMoon 2 Fund Limited Partnership Schindel Yair Chaim 10% Owner	2023-01-10 17:21:23	7,392,237 0	7,392,237	Form 13D
2	BARRETT M JAMES 10% Owner	2014-08-29 17:38:16	0 4,659,333	4,659,333	Form 4
3	BARRIS PETER J 10% Owner	2014-08-29 17:39:04	0 4,659,333	4,659,333	Form 4
4	BASKETT FOREST 10% Owner	2014-08-29 17:39:39	0 4,659,333	4,659,333	Form 4
5	SANDELL SCOTT D 10% Owner	2014-08-29 17:42:34	0 4,659,333	4,659,333	Form 4
6	KOLLURI KRISHNA KITTU 10% Owner	2014-08-29 17:41:57	0 4,659,333	4,659,333	Form 4
7	KERINS PATRICK J 10% Owner	2014-08-29 17:41:25	0 4,659,333	4,659,333	Form 4
8	DRANT RYAN D 10% Owner	2014-08-29 17:40:41	0 4,659,333	4,659,333	Form 4
9	TRAINOR III EUGENE A 10% Owner	2009-11-03 16:52:58	0 4,331,159	4,331,159	Form 4
10	LINEHAN CHARLES M 10% Owner	2009-11-03 16:52:42	0 4,331,159	4,331,159	Form 4
11	Semon Dominique 10% Owner	2010-05-04 18:36:33	0 3,921,095	3,921,095	Form 4
12	MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. UBS Oncology Impact Fund L.P. 10% Owner	2020-02-05 14:13:34	2,809,912 0	2,809,912	Form 13G
13	BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V L.P. Bay City Capital Fund V Co-Investment Fund L.P. 10% Owner	2017-11-07 16:02:35	1,828,968 0	1,828,968	Form 13D
14	WARBURG PINCUS EQUITY PARTNERS LP WARBURG PINCUS & CO Warburg Pincus Partners LLC WARBURG PINCUS LLC 10% Owner	2009-11-09 16:20:47	1,671,885 0	1,671,885	Form 13D
15	MAYFIELD IX MAYFIELD IX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND III L P MAYFIELD VIII MANAGEMENT LLC UNGER WILLIAM D AUKEN WENDELL G VAN III FONG KEVIN A MYERS FRANK G JR DALAL YOGEN K HEIDRICH A GRANT III 10% Owner	2007-02-13 17:15:27	1,298,784 0	1,298,784	Form 13G
16	CREDIT SUISSE CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS L.P. CREDIT SUISSE FIRST BOSTON EQUITY PARTNERS (BERMUDA) L.P. EMA PARTNERS FUND 2000 L.P. EMA PRIVATE EQUITY FUND 2000 L.P. CREDIT SUISSE FIRST BOSTON U.S. EXECUTIVE ADVISORS L.P. CREDIT SUISSE FIRST BOSTON ADVISORY PARTNERS LLC CREDIT SUISSE FIRST BOSTON (BERMUDA) LTD HEMISPHERE PRIVATE EQUITY PARTNERS LTD. HEMISPHERE PRIVATE EQUITY PARTNERS CHARITABLE TRUST 10% Owner	2010-02-16 15:09:55	1,206,590 0	1,206,590	Form 13G
17	ROYSTON IVOR Director	2024-11-27 16:08:36	890,179 18,599	908,778	Form 4
18	ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC ALTA BIOPHARMA MANAGEMENT III LLC PENHOET EDWARD DELEAGE JEAN CHAMPSI FARAH Former 10% Owner	2015-02-12 16:12:09	832,909 0	832,909	Form 13G
19	ALTA BIOPHARMA PARTNERS III LP MARDUEL ALIX PENHOET EDWARD ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC ALTA BIOPHARMA MANAGEMENT III LLC DELEAGE JEAN CHAMPSI FARAH 10% Owner	2015-02-12 16:12:09	832,909 0	832,909	Form 13G
20	Faerm Michael E. Chief Financial Officer	2024-05-16 16:26:48	500,000 0	500,000	Form 4
21	Quinn William P. See Remarks	2020-04-02 15:30:39	487,697 0	487,697	Form 4
22	Rothera Mark President and CEO	2024-03-13 20:36:16	475,000 0	475,000	Form 4
23	Fox Judith A. See Remarks	2020-04-02 15:25:35	457,500 0	457,500	Form 4
24	DePinto Joseph I EVP, CCO	2014-03-04 20:52:09	300,000 0	300,000	Form 4
25	Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N ELMS STEVE 10% Owner	2022-02-14 12:14:03	288,571 0	288,571	Form 13G
26	EVNIN ANTHONY B Director	2009-04-07 15:07:27	0 266,532	266,532	Form 4
27	Burcar Melody Senior VP, Finance	2024-03-22 16:07:14	260,750 0	260,750	Form 3
28	Swisher Daniel N JR President and CEO	2017-07-12 17:32:00	257,759 0	257,759	Form 4
29	Chevallard Daniel R. CFO and COO	2024-03-13 20:29:45	200,000 0	200,000	Form 4
30	Rojkjaer Lisa Chief Medical Officer	2023-03-17 17:03:25	150,000 0	150,000	Form 4
31	Pomerantz Roger Director	2024-11-27 16:06:38	144,547 0	144,547	Form 4
32	Cohen Darrel P. Chief Medical Officer	2024-03-13 20:33:00	120,000 0	120,000	Form 4
33	BJERKHOLT ERIC EVP, CFO & Corp. Secretary	2016-12-06 19:57:31	95,000 0	95,000	Form 4/A
34	Gullotta Tina VP, Finance	2020-06-05 15:18:29	90,500 0	90,500	Form 4
35	ADELMAN DANIEL C MD Sr. VP, Development and CMO	2007-09-14 17:40:07	90,000 0	90,000	Form 4
36	Roshwalb Gur Director 10% Owner	2021-03-30 20:18:29	80,000 0	80,000	Form 4
37	Pierce Valerie L SVP & General Counsel	2008-07-02 20:23:01	67,500 0	67,500	Form 4/A
38	Ketchum Steven B Director	2020-07-01 16:45:25	60,000 0	60,000	Form 4
39	Misfeldt Dayton See Remarks	2020-07-01 17:15:03	60,000 0	60,000	Form 4
40	Pearce Homer L Director	2020-07-01 17:08:17	60,000 0	60,000	Form 4
41	Wolff Henry Ward Director	2020-07-01 16:55:11	60,000 0	60,000	Form 4
42	YOUNG JAMES W Director	2020-07-01 16:52:52	60,000 0	60,000	Form 4
43	Carchedi Steve Director	2020-07-01 16:46:35	60,000 0	60,000	Form 4
44	STUMP DAVID C Director	2020-07-01 16:39:22	60,000 0	60,000	Form 4
45	McDowell Robert Scott Vice President, Research	2007-09-14 18:57:50	60,000 0	60,000	Form 4
46	Hyare Parvinder S See Remarks	2021-01-07 18:01:01	55,550 0	55,550	Form 3
47	Borellini Flavia Director	2024-06-24 19:49:14	50,000 0	50,000	Form 4
48	Barlow Jane F Director	2024-06-24 19:43:06	50,000 0	50,000	Form 4
49	Simon Barry J. Director	2024-06-24 19:44:18	50,000 0	50,000	Form 4
50	DARCY THOMAS E Director	2024-06-24 19:46:16	50,000 0	50,000	Form 4
51	Rubino Stephen Director	2024-06-24 19:39:12	50,000 0	50,000	Form 4
52	Murphy Samuel Lafayette Director	2024-06-24 19:47:16	50,000 0	50,000	Form 4
53	Chung Jane Director	2024-06-24 19:48:13	50,000 0	50,000	Form 4
54	Fust Matthew Director	2016-07-05 18:25:14	50,000 0	50,000	Form 4
55	Winter Daryl B SVP of I.P./Corp. Secretary	2006-12-04 16:52:24	45,000 0	45,000	Form 4
56	ONETTO NICOLE Director	2022-06-10 17:07:48	40,000 0	40,000	Form 4
57	Huang Michael Director	2022-06-10 16:59:21	40,000 0	40,000	Form 4
58	Kim Helen Susan Director	2015-07-01 21:09:48	40,000 0	40,000	Form 4
59	Parker Geoffrey M. Director	2017-06-02 17:22:40	25,000 0	25,000	Form 4
60	Craig Adam R EVP, Development & CMO	2015-03-02 19:49:31	23,452 0	23,452	Form 4
61	HURWITZ EDWARD Director	2013-07-02 18:56:47	20,000 0	20,000	Form 4
62	LEFF JONATHAN S Director 10% Owner	2008-06-05 16:52:07	10,000 0	10,000	Form 4
63	FODOR STEPHEN P A Director	2008-06-05 17:10:15	10,000 0	10,000	Form 4
64	Wells James A Director	2008-06-05 17:19:39	10,000 0	10,000	Form 4
65	GOLDBY STEVEN D Director	2008-06-06 14:31:16	10,000 0	10,000	Form 4
66	HIRSCH RUSSELL C Director	2005-09-27 07:56:05	0 0	0	Form 3
67	BIOGEN IDEC INC BIOGEN IDEC MA INC 10% Owner	2012-02-13 16:08:04	0 0	0	Form 13G
68	Growth Equity Opportunities Fund LLC New Enterprise Associates 12 Limited Partnership NEA Partners 12 Limited Partnership NEA 12 GP LLC 10% Owner	2021-03-10 21:40:22	0 0	0	Form 13D
69	Growth Equity Opportunities Fund LLC New Enterprise Associates 12 Limited Partnership NEA 12 GP LLC NEA Partners 12 Limited Partnership NEWHALL CHARLES W III KRAMLICH C RICHARD BARRIS PETER J PERRY MARK W BARRETT M JAMES SANDELL SCOTT D 10% Owner	2021-03-10 21:40:22	0 0	0	Form 13D

Insider Holders & Insider Ownership - Viracta Therapeutics Inc. (VIRX)